Dasatinib-induced nephrotic syndrome: a case of phenoconversion?

We present the case of a 33-year-old chronic myeloid leukemia (CML) female patient, in whom the occurrence of nephrotic syndrome, during the treatment with tyrosine kinase activity inhibitors (TKIs), was potentially influenced by transient phenoconversion. Seven years after the CML diagnosis in 2004...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandac Rogulj, Inga, Matišić, Vid, Arsov, Borna, Boban, Luka, Juginović, Alen, Molnar, Vilim, Primorac, Dragan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2019
Materias:
11th ISABS CONFERENCE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563182/
https://www.ncbi.nlm.nih.gov/pubmed/31187953
http://dx.doi.org/10.3325/cmj.2019.60.250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563182/
https://www.ncbi.nlm.nih.gov/pubmed/31187953
http://dx.doi.org/10.3325/cmj.2019.60.250

Ejemplares similares